Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-15 Purchase | 2020-12-17 5:40 pm | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 4,347 | $23 | $99,981 | 4,347 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-11 Option Award | 2023-12-13 4:05 pm | N/A 2033-12-10 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz President and COO | 260,000 | $0 | 260,000 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 8:23 pm | N/A 2033-02-09 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz President & COO | 75,000 | $0 | 75,000 (Direct) | View |
| 2022-09-23 Option Award | 2022-09-27 5:05 pm | N/A 2032-09-22 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz President & COO | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 8:40 pm | N/A 2032-08-31 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 5:39 pm | N/A 2032-01-31 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-03-08 Option Award | 2021-03-10 4:06 pm | N/A 2031-03-07 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 60,000 | $0 | 60,000 (Direct) | View |
Ownership | 2020-12-10 7:14 pm | N/A 2028-10-11 | 4D Molecular Therapeutics Inc. | FDMT | Kamal Fariborz See Remarks | 0 | $0 | 286,817 (Direct) | View |